Loading clinical trials...
Loading clinical trials...
A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)
Conditions
Interventions
Edoxaban
Standard of Care
Locations
140
United States
Banner University Medical Center
Tucson, Arizona, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
UCLA Medical Center CAR
Los Angeles, California, United States
Stanford University Medical Center
Stanford, California, United States
University of Miami Miller School of Medicine
Miami, Florida, United States
University of South Florida
Tampa, Florida, United States
Start Date
March 27, 2017
Primary Completion Date
May 24, 2022
Completion Date
May 24, 2022
Last Updated
February 28, 2025
NCT06183944
NCT06189313
NCT07015905
NCT07102160
NCT06166329
NCT07310693
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions